1,386 results on '"IgA Vasculitis diagnosis"'
Search Results
2. Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children.
- Author
-
Kaya Akca U, Batu ED, Jelusic M, Calatroni M, Bakry R, Frkovic M, Vinšová N, Campos RT, Horne A, Caglayan S, Vaglio A, Moroni G, Emmi G, Ghiggeri GM, Koker O, Sinico RA, Kim S, Gagro A, Matucci-Cerinic C, Çomak E, Ekici Tekin Z, Arslanoglu Aydin E, Heshin-Bekenstein M, Acar BC, Gattorno M, Akman S, Sozeri B, Palmblad K, Al-Mayouf SM, Silva CA, Doležalová P, Merkel PA, and Ozen S
- Subjects
- Humans, Child, Female, Male, Retrospective Studies, Adolescent, Microscopic Polyangiitis classification, Microscopic Polyangiitis diagnosis, Child, Preschool, Rheumatology standards, Polyarteritis Nodosa classification, Polyarteritis Nodosa diagnosis, Behcet Syndrome classification, Behcet Syndrome diagnosis, IgA Vasculitis diagnosis, IgA Vasculitis classification, Churg-Strauss Syndrome diagnosis, Churg-Strauss Syndrome classification, Predictive Value of Tests, Europe, Granulomatosis with Polyangiitis classification, Granulomatosis with Polyangiitis diagnosis, Takayasu Arteritis classification, Takayasu Arteritis diagnosis, Sensitivity and Specificity
- Abstract
Objective: Granulomatosis with polyangiitis (GPA) is an ANCA-associated vasculitis. The 2022 ACR/EULAR-endorsed classification criteria for GPA was derived using data only from adult patients. We aimed to assess the performance of the ACR/EULAR classification criteria for GPA in paediatric patients and compare it with the EULAR/Pediatric Rheumatology International Trials Organization (PRINTO)/Pediatric Rheumatology European Society (PReS)-endorsed Ankara 2008 criteria for GPA., Methods: Retrospective data of paediatric patients with GPA in 20 centres from 9 countries were evaluated. The diagnosis of GPA was made according to the expert opinion. The sensitivity, specificity, positive predictive value, and negative predictive value of the criteria sets were evaluated., Results: The study included 77 patients with GPA and 108 controls [IgA vasculitis (n = 44), Takayasu's arteritis (n = 20), microscopic polyangiitis (n = 16), polyarteritis nodosa (n = 14), Behçet's disease (n = 12), eosinophilic granulomatosis with polyangiitis (n = 1) and Cogan's syndrome (n = 1)] with a median age of 17.8 and 15.2 years, respectively. Among patients with GPA, constitutional symptoms (85.7%) and ENT involvement (79.2%) were the most common presentations. In the GPA group, 73 patients fulfilled the Ankara 2008 criteria and 69 the ACR/EULAR classification criteria. Sensitivities of the Ankara 2008 criteria and the ACR/EULAR classification criteria were 94.8% and 89.6%, while specificities were 95.3% and 96.3%, respectively. No significant difference was found between sensitivities and specificities of both classification criteria (P = 0.229 and P = 0.733, respectively)., Conclusion: In children, both the ACR/EULAR and EULAR/PRINTO/PReS Ankara 2008 classification criteria for GPA perform well and similarly., (© Crown copyright 2023.)
- Published
- 2024
- Full Text
- View/download PDF
3. Clinical Associations of E148Q Heterozygosity: What to Expect From E148Q?
- Author
-
Küçükali B, Bayraktar EÖ, Yıldız Ç, Gönen S, Kutlar M, Karaçayır N, Belder N, Acun B, Esmeray Şenol P, Sunar Yayla EN, Gezgin Yıldırım D, and Bakkaloğlu SA
- Subjects
- Humans, Female, Male, Child, Child, Preschool, Adolescent, IgA Vasculitis genetics, IgA Vasculitis diagnosis, Mutation, Familial Mediterranean Fever genetics, Familial Mediterranean Fever diagnosis, Familial Mediterranean Fever drug therapy, Familial Mediterranean Fever physiopathology, Pyrin genetics, Heterozygote, Colchicine therapeutic use
- Abstract
Objective: The exact effects of MEFV variants on inflammation are still under investigation, and reports on variants of unknown significance, particularly the E148Q variant, have been conflicting. Therefore, this study aims to investigate patients exhibiting E148Q heterozygosity, focusing on diagnoses and disease courses to assist physicians in interpreting the variant., Methods: Data of pediatric patients presenting to the Pediatric Rheumatology clinic between November 2016 and September 2023, exhibiting only E148Q heterozygosity in MEFV gene analysis, were extracted. Patients who were lost before 9 months of follow-up have been excluded to ensure the completion of initial diagnostic tests and evaluations., Results: Among the 119 patients with E148Q variant, the diagnoses were as follows: healthy, 51.3%; IgA vasculitis, 10.1%; Familial Mediterranean Fever (FMF), 7.6%; Periodic fever, Aphtous stomatitis, Pharyngitis, Adenitis (PFAPA), 6.7%; and other diagnoses, 19.3%. IgA vasculitis patients experienced articular, gastrointestinal, and renal involvement at rates of 91.7%, 58.3%, and 16.7%, respectively. Complete response, partial response, and no response to colchicine were 37.5%, 12.5%, and 50%, respectively, in PFAPA patients. All FMF patients responded to colchicine treatment resulting in reduced mean FMF episode counts in 6 months from 3.22 ± 0.92 to 0.56 ± 0.52., Conclusions: The E148Q variant may amplify inflammation and modify disease courses. Patients with the E148Q variant experiencing typical FMF episodes should receive colchicine, but clinicians should exercise caution regarding alternative diagnoses. Additionally, the E148Q variant may increase acute phase reactants and disease severity in IgA vasculitis. However, to reach definitive conclusions on its treatment-modifying role in PFAPA, universal diagnosis and treatment response criteria should be adopted., Competing Interests: Conflicts of interest: No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
4. An Unusual Case of Abdominal Pain in a Geriatric Man.
- Author
-
Sloane S, Olandt CA, Subramony R, and Campbell C
- Subjects
- Humans, Male, Aged, Acute Kidney Injury etiology, Emergency Service, Hospital organization & administration, Edema etiology, Abdominal Pain etiology, IgA Vasculitis complications, IgA Vasculitis diagnosis, IgA Vasculitis physiopathology
- Abstract
Background: Immunoglobulin A vasculitis, historically known as Henoch-Schönlein purpura, is a rare form of autoimmune-induced vasculitis most common in children. This disease is characterized by a purpuric rash, arthritis, digestive tract complication, and renal inflammation (Hopkins)., Case Report: We present the case of a 78-year-old man in the emergency department with findings of weakness, abdominal pain, and bloody diarrhea for 3 days and a new-onset bilateral lower extremity rash. Diagnostic imaging and labs diagnosed this patient with immunoglobulin A vasculitis (IgAV) with associated acute kidney injury and abdominal mesenteric edema. Why Should an Emergency Physician be Aware of This? Recognition of IgAV by emergency physicians and assessment of multiple organ involvement is critical to expedite treatment and minimize complications. Particularly, physicians should consider and recognize the increased severity and different presentation of IgAV in adults in comparison with the more widely known manifestation in children., Competing Interests: Declaration of competing interest None., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
5. IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report.
- Author
-
Terashima Y, Matsumoto M, Ozaki S, Nakagawa M, Nakagome S, Terasaki Y, Iida H, Mitsugi R, Kuramochi E, Okada N, Inoue T, Matsuki S, Kitagawa S, Fukuizumi A, Onda N, Takeuchi S, Miyanaga A, Kasahara K, and Seike M
- Subjects
- Humans, Male, Aged, IgA Vasculitis chemically induced, IgA Vasculitis diagnosis, Immunoglobulin A, Immune Checkpoint Inhibitors adverse effects, Carboplatin adverse effects, Carboplatin administration & dosage, Carboplatin therapeutic use, Paclitaxel adverse effects, Paclitaxel administration & dosage, Paclitaxel therapeutic use, Antibodies, Monoclonal, Humanized adverse effects, Antibodies, Monoclonal, Humanized therapeutic use, Antibodies, Monoclonal, Humanized administration & dosage, Lung Neoplasms drug therapy, Antineoplastic Combined Chemotherapy Protocols adverse effects, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma, Squamous Cell drug therapy, Albumins adverse effects, Albumins administration & dosage
- Abstract
A 73-year-old man with lung squamous cell carcinoma was administered carboplatin + nab-paclitaxel + pembrolizumab for four cycles. Subsequently, he presented with multiple purpuras on his extremities, joint swelling on his fingers, abdominal pain, and diarrhea, accompanied by acute kidney injury (AKI), increased proteinuria, hematuria, and elevated C-reactive protein levels. Skin biopsy showed leukocytoclastic vasculitis as well as IgA and C3 deposition in the vessel walls. Based on these findings, the patient was diagnosed with IgA vasculitis as an immune-related adverse event (irAE) induced by carboplatin + nab-paclitaxel + pembrolizumab. After discontinuation of pembrolizumab and glucocorticoids, the symptoms immediately resolved. Regular monitoring of skin, blood tests, and urinalysis are necessary, and the possibility of irAE IgA vasculitis should be considered in cases of purpura and AKI during treatment with immune checkpoint inhibitors., Competing Interests: AM has received honoraria from AstraZeneca, Nippon Kayaku, Merck, Kyowa Kirin, and Pfizer. KK has received honoraria Chugai Pharmaceutical, Eli Lilly, and Bristol-Myers Squibb. MS has received grants and contracts from any entity from Taiho Pharmaceutical, Chugai Pharmaceutical, Eli Lilly, Nippon Boehringer Ingelheim, Nippon Kayaku, and Kyowa Hakko Kirin; honoraria from AstraZeneca, MSD K.K, Chugai Pharmaceutical, Taiho Pharmaceutical, Eli Lilly, Ono Pharmaceutical, Bristol-Myers Squibb, Nippon Boehringer Ingelheim, Pfizer, Novartis, Takeda Pharmaceutical, Kyowa Hakko Kirin, Nippon Kayaku, Daiichi-Sankyo Company, Merck Biopharma, and Amgen. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Terashima, Matsumoto, Ozaki, Nakagawa, Nakagome, Terasaki, Iida, Mitsugi, Kuramochi, Okada, Inoue, Matsuki, Kitagawa, Fukuizumi, Onda, Takeuchi, Miyanaga, Kasahara and Seike.)
- Published
- 2024
- Full Text
- View/download PDF
6. Unusual endoscopic appearance of the rectum in a patient with Henoch-Schönlein purpura.
- Author
-
Hu Y, Ding J, and Wang Q
- Subjects
- Humans, Male, Colonoscopy, IgA Vasculitis complications, IgA Vasculitis diagnosis, Rectum pathology, Rectum diagnostic imaging
- Abstract
Competing Interests: Conflict of Interest Statement The authors have no conflicts of interest to declare.
- Published
- 2024
- Full Text
- View/download PDF
7. Outcome of immunosuppression in children with IgA vasculitis-related nephritis.
- Author
-
Rohner K, Marlais M, Ahn YH, Ali A, Alsharief A, Novak AB, Brambilla M, Cakici EK, Candan C, Canpolat N, Chan EY, Decramer S, Didsbury M, Durao F, Durkan AM, Düzova A, Forbes T, Gracchi V, Güngör T, Horinouchi T, Kasap Demir B, Kobayashi Y, Koskela M, Kurt-Sukur ED, La Scola C, Langan D, Li X, Malgieri G, Mastrangelo A, Min J, Mizerska-Wasiak M, Moussaoui N, Noyan A, Nuutinen M, O'Gormon J, Okamoto T, Oni L, Oosterveld M, Pańczyk-Tomaszewska M, Parmaksiz G, Pasini A, Rianthavorn P, Roelofs J, Shen Y, Sinha R, Topaloglu R, Torres DD, Udagawa T, Wennerström M, Yap YC, and Tullus K
- Subjects
- Humans, Male, Child, Female, Retrospective Studies, Adolescent, Child, Preschool, Prognosis, Glomerulonephritis, IGA drug therapy, Glomerulonephritis, IGA pathology, Follow-Up Studies, Immunosuppression Therapy methods, IgA Vasculitis drug therapy, IgA Vasculitis complications, IgA Vasculitis diagnosis, Treatment Outcome, Vasculitis drug therapy, Glomerular Filtration Rate, Immunosuppressive Agents therapeutic use
- Abstract
Background: Immunoglobulin A vasculitis with nephritis (IgAVN) is the most common vasculitis in children. Due to a lack of evidence, treatment recommendations are based on expert opinion, resulting in variation. The aim of this study was to describe the clinical presentation, treatment and outcome of an extremely large cohort of children with biopsy-proven IgAVN in order to identify prognostic risk factors and signals of treatment efficacy., Methods: Retrospective data were collected on 1148 children with biopsy-proven IgAVN between 2005 and 2019 from 41 international paediatric nephrology centres across 25 countries and analysed using multivariate analysis. The primary outcome was estimated glomerular filtration rate (eGFR) and persistent proteinuria at last follow-up., Results: The median follow-up was 3.7 years (interquartile range 2-6.2). At last follow-up, 29% of patients had an eGFR <90 mL/min/1.73 m2, 36% had proteinuria and 3% had chronic kidney disease stage 4-5. Older age, lower eGFR at onset, hypertension and histological features of tubular atrophy and segmental sclerosis were predictors of poor outcome. There was no evidence to support any specific second-line immunosuppressive regimen being superior to others, even when further analysing subgroups of children with reduced kidney function, nephrotic syndrome or hypoalbuminemia at onset. Delayed start of immunosuppressive treatment was associated with a lower eGFR at last follow-up., Conclusion: In this large retrospective cohort, key features associated with disease outcome are highlighted. Importantly, there was no evidence to support that any specific immunosuppressive treatments were superior to others. Further discovery science and well-conducted clinical trials are needed to define accurate treatment and improve outcomes of IgAVN., (© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA.)
- Published
- 2024
- Full Text
- View/download PDF
8. UK Kidney Association guideline review: 'The initial management of IgA vasculitis (Henoch-Schönlein purpura) in children and young people' in conjunction with 'The management of complications-associated IgA vasculitis (Henoch-Schönlein purpura) in children and young people'.
- Author
-
Day C and Shute R
- Subjects
- Humans, Child, Adolescent, United Kingdom, Practice Guidelines as Topic, Child, Preschool, Male, Female, IgA Vasculitis diagnosis, IgA Vasculitis complications, IgA Vasculitis therapy
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2024
- Full Text
- View/download PDF
9. Case report: Propylthiouracil-induced serious side effect: Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis or IgA vasculitis?
- Author
-
Zhang W, Liu X, Wang X, Ma H, and Zhang P
- Subjects
- Humans, Female, Pregnancy, Adult, Graves Disease drug therapy, IgA Vasculitis chemically induced, IgA Vasculitis diagnosis, IgA Vasculitis immunology, Antibodies, Antineutrophil Cytoplasmic blood, Antibodies, Antineutrophil Cytoplasmic immunology, Propylthiouracil adverse effects, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis chemically induced, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis diagnosis, Antithyroid Agents adverse effects, Antithyroid Agents therapeutic use
- Abstract
Introduction: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare disease characterized by the inflammation and destruction of small blood vessels and circulating ANCAs. Drugs such as antithyroid drugs (ATDs), especially propylthiouracil (PTU), have been used for the production of ANCAs and cause the development of drug-induced AAV. The pathogenesis of this disease is unclear but could be related to the physiological processes affecting the degradation of neutrophil extracellular traps (NETs). At present, PTU is widely used in patients with Graves' disease (GD) who are preparing for pregnancy and whose condition has not been controlled. Once drug-induced AAV has occurred with important organ damage, considering NETs have a significant role in the immune system, whether the cessation of drugs could stop the progression of organ damage is unclear, and a consensus regarding standard treatment has not been established., Patient Concerns: In this case report, a female patient who planned pregnancy was hospitalized with multiple joint pain, impaired renal function, and hematuria. Immunofluorescence of the renal biopsy demonstrated spherical and diffuse mesangial distribution of IgA (3+). Autoimmune serology demonstrated positivity for autoantibodies against p-ANCA and an anti-MPO titer 74.72 RU/mL., Diagnosis: She was diagnosed with PTU-induced p-ANCA-associated and IgA-associated vasculitis (IgAV)., Interventions: The patient accepted low doses of glucocorticoid, immunosuppressive therapy and RAI treatment., Outcomes: Both her kidney function and thyroid function remained were on the mend., Conclusion: The authors believe that this type of patient needs to fully consider their pregnancy preparation needs, suspend pregnancy when a small chance of GD remission is indicated, and avoid the use of drugs with reproductive toxicity and other serious adverse events. The multidisciplinary combination therapy of low-dose glucocorticoids and immunosuppressants combined with iodine radiotherapy is one reasonable scheme. At the same time, it is necessary to eliminate the organ damage caused by other reasons. This report provides a clinical treatment basis for patients with drug-induced vasculitis manifestations who cannot receive an accurate diagnosis., Competing Interests: The authors have no conflicts of interest to disclose., (Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
10. Posterior reversible encephalopathy syndrome in the setting of IgA vasculitis.
- Author
-
Fanous N, Clarke E, and Levy ML
- Subjects
- Humans, Male, Female, Immunoglobulin A, Child, Posterior Leukoencephalopathy Syndrome diagnosis, Posterior Leukoencephalopathy Syndrome etiology, IgA Vasculitis complications, IgA Vasculitis diagnosis, Magnetic Resonance Imaging
- Abstract
IgA vasculitis (IgAV), formerly known as Henoch-Scholein purpura, is a small vessel vasculitis, most commonly seen in pediatric patients, that can affect numerous internal organs including the kidneys, lungs, gastrointestinal tract, and the central nervous system (CNS). CNS manifestations of this condition include hypertensive encephalopathy, thrombosis, optic neuropathy, seizures, CNS vasculitis, and a more recently described phenomenon known as posterior reversible encephalopathy syndrome (PRES). Symptoms of PRES include hypertension, altered mental status, and seizures caused by vasogenic disruption of the blood-brain barrier, and the condition is diagnosed by characteristic edema-related gray-white matter changes in the parieto-occipital lobes on magnetic resonance imaging. Herein, we present a rare case of PRES as a presenting sign of IgAV to increase awareness about this unusual association., (© 2024 Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
11. Immunoglobulin A vasculitis: The clinical features and pathophysiology.
- Author
-
Hu YC, Yang YH, and Chiang BL
- Subjects
- Humans, Vasculitis immunology, Vasculitis physiopathology, SARS-CoV-2 immunology, IgA Vasculitis immunology, IgA Vasculitis physiopathology, IgA Vasculitis diagnosis, Autoantibodies immunology, Neutrophils immunology, Immunoglobulin A immunology, COVID-19 immunology, COVID-19 physiopathology, COVID-19 virology, COVID-19 complications
- Abstract
Palpable purpura, gastrointestinal symptoms, joint involvement, and renal disease characterize immunoglobulin A vasculitis (IgAV). Renal involvement ranging from mild proteinuria to severe nephritic or nephrotic syndrome highlights the importance of monitoring kidney function in patients with IgAV. Recognizing these key features is crucial for early diagnosis and appropriate management to prevent long-term complications related to kidney disease. However, the pathogenesis of IgAV remains unclear. Disease mechanisms involve various factors, including the interplay of aberrantly glycosylated IgA, anti-endothelial cell antibodies, and neutrophils following infection triggers, which are the main pathogenic mechanisms of IgAV. Insights from cases of IgAV related to Coronavirus disease 2019 have offered additional understanding of the connection between infection and IgAV pathogenesis. This review provides a valuable resource for healthcare professionals and rheumatology researchers seeking a better understanding of the clinical features and pathophysiology of IgAV., (© 2024 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia, Ltd on behalf of Kaohsiung Medical University.)
- Published
- 2024
- Full Text
- View/download PDF
12. Severe immunoglobulin A vasculitis with refractory gastrointestinal involvement in an adult patient successfully treated with plasma exchange.
- Author
-
Codullo V, Monti S, Perotti C, Milanesi A, Rossi S, Gallotti A, Cobianchi L, Montecucco C, and Delvino P
- Subjects
- Adult, Humans, Male, Gastrointestinal Diseases, IgA Vasculitis complications, IgA Vasculitis therapy, IgA Vasculitis diagnosis, IgA Vasculitis drug therapy, Immunoglobulin A blood, Treatment Outcome, Vasculitis drug therapy, Vasculitis immunology, Plasma Exchange methods
- Published
- 2024
- Full Text
- View/download PDF
13. IgA vasculitis after COVID-19: a case-based review.
- Author
-
Suszek D, Grzywa-Celińska A, Emeryk-Maksymiuk J, Krusiński A, Redestowicz K, and Siwiec J
- Subjects
- Humans, Female, Middle Aged, Immunoglobulin A blood, Immunoglobulin A immunology, COVID-19 complications, COVID-19 immunology, IgA Vasculitis immunology, IgA Vasculitis diagnosis, IgA Vasculitis complications, IgA Vasculitis drug therapy, SARS-CoV-2 immunology
- Abstract
IgA-associated vasculitis (IgAV) known as Henoch - Schönlein purpura (HSP) disease is an inflammatory disorder of small blood vessels. It's the most common type of systemic vasculitis in children which can be associated with the inflammatory process following infections. IgA vasculitis is a rare and poorly understood systemic vasculitis in adults. Coronavirus disease 2019 (COVID-19) has been associated with HSP in both adults and children. A 58-year-old woman was diagnosed with HSP, fulfilling the clinical criteria: palpable purpura, arthritis, hematuria. The disclosure of the HSP disease was preceded by a infection of the respiratory tract. COVID-19 infection was confirmed via the presence of IgM and IgG antibodies. This case indicates the possible role of SARS-CoV-2 in the development of HSP. The clinical course of IgAV in adults appears to be different from pediatric IgAV, especially due to higher risk of renal complications. Symptoms of the disease quickly resolved with low-dose of steroids., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
14. Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites.
- Author
-
Yu M, Song X, Guo J, Feng Q, and Tian J
- Subjects
- Humans, Male, Female, Child, Pilot Projects, Case-Control Studies, Child, Preschool, Chromatography, Liquid, Tandem Mass Spectrometry, Adolescent, IgA Vasculitis urine, IgA Vasculitis complications, IgA Vasculitis diagnosis, Nephritis urine, Nephritis etiology, Biomarkers urine, Metabolomics methods
- Abstract
Henoch-Schönlein purpura nephritis (HSPN) is the most severe manifestation of Henoch-Schönlein purpura (HSP). This study aimed to determine the role of urine metabolomics in predicting HSPN and explore the potential mechanisms of HSP. A liquid chromatography-tandem mass spectrometry-based untargeted metabolomics analysis was performed to investigate the urinary metabolic profiles of 90 participants, comprising 30 healthy children (group CON) and 60 patients with HSP, including 30 HSP patients without renal involvement (group H) and 30 HSPN patients (group HSPN). The differentially expressed metabolites (DEMs) were identified using orthogonal partial least squares discriminant analysis (OPLS-DA), and subsequent bioinformatics analysis was conducted to elucidate the perturbed metabolic pathways. A total of 43 DEMs between H and HSPN groups were analyzed by the Kyoto Encyclopedia of Gene and Genome (KEGG) database, and the result indicates that glycine, serine and threonine metabolism, and cysteine and methionine metabolism were significantly disturbed. A composite model incorporating propionylcarnitine and indophenol sulfate was developed to assess the risk of renal involvement in pediatric patients with HSP. Conclusion: This study reveals the metabolic alterations in healthy children, HSPN patients, and HSP patients without renal involvement. Furthermore, propionylcarnitine and indophenol sulfate may be potential predictive biomarkers of the occurrence of HSPN. What is Known: • HSP is the predominant type of vasculitis observed in children. The long-term prognosis of HSP is contingent upon the extent of renal impairment. In severe nephritis, a delay in appropriate treatment may lead to fibrosis progression and subsequent development of chronic kidney disease (CKD), even leading to renal failure. • The application of metabolomics in investigating diverse renal disorders has been documented. Urine is a robust and sensitive medium for metabolomics detection. What is New: • The metabolic profiles were identified in urine samples of healthy children and those with HSP at the early stage of the disease. Different metabolites were identified between HSP patients without nephritis and those who developed HSPN. • These different metabolites may affect oxidative stress in the progression of HSPN., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
15. Anti-Smith and Anti-Double-Stranded DNA Antibodies in a Patient With Henoch-Schönlein Purpura Following COVID-19 Vaccination.
- Author
-
Tepp JA, Husain S, Paragh L, and Levit EK
- Subjects
- Humans, Antibodies, Antinuclear blood, Antibodies, Antinuclear immunology, COVID-19 prevention & control, COVID-19 complications, Male, SARS-CoV-2 immunology, Female, IgA Vasculitis diagnosis, IgA Vasculitis chemically induced, COVID-19 Vaccines adverse effects, COVID-19 Vaccines administration & dosage
- Published
- 2024
- Full Text
- View/download PDF
16. Association of axial spondyloarthritis and IgA vasculitis: Report of two cases.
- Author
-
Demouveaux A, Delclaux M, Goudot A, Duponchelle E, Cortet B, Flipo RM, and Letarouilly JG
- Subjects
- Humans, Male, Female, Immunoglobulin A immunology, Immunoglobulin A blood, Adult, Middle Aged, IgA Vasculitis diagnosis, IgA Vasculitis complications, IgA Vasculitis immunology, Vasculitis diagnosis, Vasculitis immunology, Axial Spondyloarthritis diagnosis
- Published
- 2024
- Full Text
- View/download PDF
17. Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China.
- Author
-
Wang Y, Zhang L, Yuan L, Xie Q, Liu S, and Hao CM
- Subjects
- Humans, China epidemiology, Male, Retrospective Studies, Adult, Female, Middle Aged, Biopsy statistics & numerical data, Young Adult, Adolescent, Lupus Nephritis pathology, Lupus Nephritis epidemiology, Aged, IgA Vasculitis pathology, IgA Vasculitis epidemiology, IgA Vasculitis diagnosis, Glomerulonephritis pathology, Glomerulonephritis epidemiology, Kidney Diseases pathology, Kidney Diseases epidemiology, Kidney Diseases diagnosis, Glomerulonephritis, Membranous pathology, Glomerulonephritis, Membranous epidemiology, Glomerulonephritis, IGA pathology, Glomerulonephritis, IGA epidemiology, Glomerulosclerosis, Focal Segmental pathology, Glomerulosclerosis, Focal Segmental epidemiology, Nephrosis, Lipoid pathology, Nephrosis, Lipoid epidemiology, Kidney pathology
- Abstract
Background: There have been some shifts in the frequency and distribution of biopsy-proven renal diseases in China over recent years. The aim of the study was to investigate the changing spectrum of renal diseases from the view of kidney biopsy data in a single center of China., Methods and Results: A total of 10,996 cases of native renal biopsies from patients aged ≥15 years old in Huashan Hospital, Fudan University, between 2008 and 2018 were analyzed retrospectively. The results showed that primary glomerular nephropathy (PGN) remained the most common biopsy-proven renal disease (69.42% of total), with IgA nephropathy (IgAN) accounting for 44.40% of PGN, membranous nephropathy (MN) for 28.55%, minimal change disease (MCD) for 13.26% and focal segmental glomerulosclerosis (FSGS) for 8.00%. During the study period, the proportion of MN in PGN appeared an increasing tendency, while that of IgAN and MCD remained stable and that of FSGS showed a decline. Secondary glomerular nephropathy (SGN) constituted 21.54% of total cases, among which the leading two diseases were lupus nephritis (LN) and Henoch-Schonlein purpura nephritis (HSN) which accounted for 41.08% and 19.11% respectively., Conclusions: The 11-year retrospective study revealed that PGN was the predominant histologic diagnosis among patients undergoing renal biopsy and the most frequent type of PGN remained to be IgAN, followed by MN which increased dramatically.
- Published
- 2024
- Full Text
- View/download PDF
18. Predicting renal damage in children with IgA vasculitis by machine learning.
- Author
-
Pan M, Li M, Li N, and Mao J
- Subjects
- Humans, Male, Female, Child, Prognosis, Adolescent, Retrospective Studies, Risk Factors, Kidney pathology, Kidney immunology, Child, Preschool, Machine Learning, IgA Vasculitis diagnosis, IgA Vasculitis blood, IgA Vasculitis complications, IgA Vasculitis immunology
- Abstract
Background: Children with IgA Vasculitis (IgAV) may develop renal complications, which can impact their long-term prognosis. This study aimed to build a machine learning model to predict renal damage in children with IgAV and analyze risk factors for IgA Vasculitis with Nephritis (IgAVN)., Methods: 50 clinical indicators were collected from 217 inpatients at our hospital. Six machine learning algorithms-Logistic Regression, Linear Discriminant Analysis, K-Nearest Neighbor, Support Vector Machine, Decision Trees, and Random Forest-were utilized to select the model with the highest predictive performance. A simplified model was developed through feature importance ranking and validated by an additional cohort with 46 patients., Results: The random forest model had the highest accuracy, precision, recall, F1 score, and area under the curve, with values of 0.91, 0.98, 0.70, 0.79 and 0.94, respectively. The top 11 features according to the importance ranking were anti-streptolysin O, corticosteroids therapy, antihistamine therapy, absolute eosinophil count, immunoglobulin E, anticoagulant therapy, C-reactive protein, prothrombin time, age at onset, D-dimer, recurrence of rash ≥ 3 times. A simplified model using these features demonstrated optimal performance with an accuracy of 84.2%, a sensitivity of 89.4%, and a specificity of 82.5% in external validation. Finally, we provided a web tool based on the simplified model, whose code was published on https://github.com/mulanruo/IgAVN_Prediction ., Conclusion: The model based on the random forest algorithm demonstrates good performance in predicting renal damage in children with IgAV, providing a basis for early clinical diagnosis and decision-making., (© 2024. The Author(s), under exclusive licence to International Pediatric Nephrology Association.)
- Published
- 2024
- Full Text
- View/download PDF
19. An Unusual Case of Alcoholic Liver Disease Associated with Secondary IgA Vasculitic Nephritis presenting as Rapidly Progressive Glomerulonephritis.
- Author
-
Muralidharan S, Mathew GG, Jayaprakash V, and Sailapathy S
- Subjects
- Humans, Male, Middle Aged, Disease Progression, Liver Diseases, Alcoholic complications, IgA Vasculitis complications, IgA Vasculitis diagnosis, IgA Vasculitis drug therapy, Vasculitis complications, Vasculitis etiology, Vasculitis diagnosis, Vasculitis drug therapy, Glomerulonephritis, IGA complications, Glomerulonephritis, IGA diagnosis
- Abstract
IgA nephropathy (IgAN) is a fairly common association with alcoholic liver disease. However, IgA vasculitis (IgAV) is quite an uncommon association with alcoholic liver cirrhosis and only a handful of cases have been reported in literature. Secondary IgAN usually presents in a docile manner, progressing slowly in about 5-25 years. It is usually responsive to steroid therapy, very rarely progressing to End-Stage Renal Disease. Here, we present a man in his late 50s, a known hypertensive and alcohol related liver-cirrhotic, who presented to our hospital with rash and rapidly progressive renal failure (RPRF). He was diagnosed with IgA nephritis with IgA vasculitis (IgAVN). His diagnosis was confirmed with skin and renal biopsy. He was started on renal replacement therapy for his renal failure and began oral steroid therapy. After administration of steroid therapy for 6 months, the patient recovered and was dialysis independent with stable renal parameters., (Copyright by Società Italiana di Nefrologia SIN, Rome,Italy.)
- Published
- 2024
- Full Text
- View/download PDF
20. Adult Henoch-Schönlein purpura complicated by IgA-nephritis in a patient with mantle cell lymphoma and Graves disease.
- Author
-
Gambichler T, Sandersfeld MH, Schaller J, Wiech T, Zimmermann T, Özcan F, and Susok L
- Subjects
- Humans, Male, Middle Aged, IgA Vasculitis complications, IgA Vasculitis diagnosis, Lymphoma, Mantle-Cell complications, Lymphoma, Mantle-Cell pathology, Graves Disease complications, Glomerulonephritis, IGA complications, Glomerulonephritis, IGA pathology
- Published
- 2024
- Full Text
- View/download PDF
21. Immunoglobulin A Vasculitis With Intussusception in Children.
- Author
-
Liu C, Du LN, Zhao Q, Wang XT, Feng K, Yang Y, and Yang Y
- Subjects
- Humans, Male, Female, Child, Child, Preschool, Infant, Ileal Diseases diagnosis, Ileal Diseases therapy, Ileal Diseases etiology, Ileal Diseases surgery, Retrospective Studies, Ultrasonography, IgA Vasculitis complications, IgA Vasculitis diagnosis, Adolescent, Enema, Immunoglobulin A, Intussusception diagnosis, Intussusception surgery, Intussusception etiology, Intussusception therapy
- Abstract
Background: Immunoglobulin A (IgA) vasculitis with intussusception is acute and severe vasculitis combined with acute abdomen in children. The diagnosis of the disease depends on the results of imaging examinations, and its treatment mainly includes enema and surgery. The literature summarized the detailed diagnosis and treatment data in previous literature reports., Methods: We described the clinical manifestations, ultrasonic features, and treatment of patients admitted to a single center and reviewed previous literature regarding cases with detailed clinical data in the PubMed database within the past 20 years., Results: The review included 36 patients, including 22 boys and 14 girls. A total of 32 patients were diagnosed using ultrasound (88.9%). The main sites of intussusception were the ileum and ileocolon in 16 (44.4%) and 11 (30.6%) cases, respectively. Thirteen patients (36.1%) were treated with enema, with 6 responding to the treatment. 26 patients (72.2%) underwent surgical treatment. Patients with ileal intussusception were more likely to be treated with surgery than those with colonic intussusception ( P < .05). The single-center clinical data of 23 patients showed that there was no significant difference in laboratory test findings between patients with and without surgical treatment ( P > .05). Patients with long insertion lengths were more likely to require surgery and resection ( P < .05)., Conclusions: Ultrasonography is the first-line investigation for diagnosis. The main sites of intussusception were ileum and ileocolon. The length of intubation was related to surgery; treatment is according to the intussusception site. Air enema is not suitable for intussusception of the small intestine., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
22. Duodenal and jejunal involvement by IgA vasculitis.
- Author
-
Han DG, Huang C, and Liu W
- Subjects
- Humans, Duodenal Diseases diagnostic imaging, Duodenal Diseases pathology, Duodenal Diseases complications, Duodenum pathology, Duodenum diagnostic imaging, IgA Vasculitis diagnosis, IgA Vasculitis complications, Jejunal Diseases diagnostic imaging, Jejunum pathology, Jejunum diagnostic imaging, Vasculitis complications, Vasculitis diagnosis, Vasculitis pathology, Immunoglobulin A
- Abstract
Competing Interests: Declaration of competing interest The authors have no conflicts of interest to declare.
- Published
- 2024
- Full Text
- View/download PDF
23. Gastrointestinal bleeding in children with Henoch-Schönlein purpura combined with prognostic nutrition index may predict endoscopic duodenal ulcers during hospitalization: A single-center retrospective case-control study.
- Author
-
Li C, Sun L, Feng X, and Lei C
- Subjects
- Humans, Male, Child, Female, Retrospective Studies, Case-Control Studies, Prognosis, Child, Preschool, Hospitalization statistics & numerical data, Nutrition Assessment, Endoscopy, Digestive System methods, Risk Factors, Adolescent, China epidemiology, IgA Vasculitis complications, IgA Vasculitis diagnosis, Duodenal Ulcer complications, Gastrointestinal Hemorrhage etiology, Gastrointestinal Hemorrhage diagnosis
- Abstract
Duodenal ulcer (DU) is the most common gastroscopic manifestation of abdominal Henoch-Schönlein purpura (HSP), which may cause severe bleeding and often requires esophagogastroduodenoscopy (EGD) to confirm the diagnosis. However, the condition of children with HSP changes rapidly; not all children are able to undergo EGD on time, and some hospitals do not have a pediatric EGD unit. Therefore, assessing the risk factors for developing DU in HSP using simple and readily available indicators is essential. Children with HSP at Wuhan Children Hospital from June 2020 to June 2022 were included in the training set and completed EGD. The patients were divided into 2 groups: those with (DU group) and without DU (non-DU group). Data were collected from the 2 groups, and univariate and multivariate logistic regression analyses were used to compare the 2 groups. Children with HSP admitted between July 2022 and June 2023 were included in the validation set. Four indicators, prognostic nutrition index, albumin (ALB), gastrointestinal (GI) bleeding, and duration of onset before EGD, were found in the DU and non-DU groups. GI bleeding and prognostic nutritional index (PNI) ≤ 53.0 have strong predictability for patients with HSP and DU. GI bleeding and PNI ≤ 53.0 may provide new reference evidence for condition assessment and treatment., Competing Interests: The authors have no conflicts of interest to disclose., (Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
24. A specific diagnostic metabolome signature in adult IgA vasculitis.
- Author
-
Boissais A, Blasco H, Emond P, Lefèvre A, Bigot A, Ramdani Y, Maldent NF, Mulleman D, Pillebout E, Maillot F, and Audemard-Verger A
- Subjects
- Humans, Female, Male, Middle Aged, Adult, Chromatography, High Pressure Liquid, Vasculitis diagnosis, Vasculitis metabolism, Vasculitis blood, Metabolomics methods, Aged, Mass Spectrometry methods, IgA Vasculitis diagnosis, IgA Vasculitis blood, IgA Vasculitis metabolism, Metabolome, Biomarkers blood, Immunoglobulin A blood
- Abstract
Introduction: IgA vasculitis diagnosis relies primarily on clinical features and is confirmed by pathological findings. To date, there is no reliable noninvasive diagnostic biomarker., Objective: We aimed to explore the baseline serum metabolome of adult patients with IgA vasculitis to identify potential diagnostic biomarkers., Methods: We performed a study comparing the serum metabolome of patients with IgA vasculitis to that of patients with inflammatory condition, namely spondyloarthritis. Serum analyses were performed by high-performance liquid chromatography-mass spectrometry., Results: Fifty-five patients with IgA vasculitis and 77 controls with spondyloarthritis (age- and sex-matched) were included in this study. The median age of IgA vasculitis patients was 53 years. Two-thirds of patients were female (n = 32). At the time of vasculitis diagnosis, 100% of patients had skin involvement and 69% presented with glomerulonephritis (n = 38). Joint and digestive involvement were observed in 56% (n = 31) and 42% (n = 23) of patients. Four discriminative metabolites between the two groups were identified: 1-methyladenosine, L-glutamic acid, serotonin, and thymidine. The multivariate model built from the serum metabolomes of patients with IgA vasculitis and spondyloarthritis revealed an accuracy > 90%. As this model was significant according to the permutation test (p < 0.01), independent validation showed an excellent predictive value of the test set: sensitivity 98%; specificity 98%, positive predictive value 97% and negative predictive value 98%., Conclusion: To our knowledge, this study is the first to use the metabolomic approach for diagnostic purposes in adult IgA vasculitis, highlighting a specific diagnostic metabolome signature., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
25. Scurvy masquerading as IgA vasculitis.
- Author
-
Kassa HL, Singh S, Douglas-Jones M, Schermbrucker G, De Lange J, Phoya F, Butters C, Hlela C, Coetzee A, Banderker E, and Webb K
- Subjects
- Humans, Male, Adolescent, Diagnosis, Differential, IgA Vasculitis diagnosis, Scurvy diagnosis, Ascorbic Acid therapeutic use
- Abstract
Background: Vitamin C deficiency, or scurvy, is rare but poses risks for children with poor diets, limited resources, or malabsorption issues. It may also be common in children with restrictive or selective dietary habits in children with global developmental delay, autism spectrum disorder, and physical disabilities. Symptoms include fatigue, irritability, joint and muscle pain, joint swellings, edema, swollen gums, easy bruising, and delayed wound healing. Early recognition and prompt intervention are essential to prevent the progression of symptomatic vitamin C deficiency in children., Case Presentation: We present a case of a 13-year-old boy with developmental delay secondary to Lennox Gastaut syndrome referred for suspected recurrent, severe, and atypical IgA vasculitis. He presented with irritability, loss of appetite, petechial and ecchymotic lower limb lesions, unilateral gum swelling, severe arthritis, peripheral oedema, severe weight loss, anaemia, and raised inflammatory markers. Multiple investigations were performed before the diagnosis of scurvy was made. A surgical finding of friable gingival tissue with multiple loose teeth, a skin biopsy with follicular hyperkeratosis and extravasated perifollicular red blood cells, and a typical X-ray finding led to the diagnosis of scurvy., Conclusion: Scurvy should be given careful consideration as a differential diagnosis in patients presenting with musculoskeletal issues, mucocutaneous complaints, and constitutional symptoms such as malaise, asthenia, irritability, and loss of appetite. A focused and detailed dietary history looking for a lack of good sources of vitamin C can be an easy indicator of this differential. Imaging studies revealing the typical features can also help make the diagnosis. Pathology of the skin revealing pathognomonic features can add to the certainty of the diagnosis. In the absence of all else, the rapid response to treatment with an appropriate dose of vitamin C has a diagnostic and therapeutic role., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
26. Terminal ileitis: a rare gastrointestinal manifestation of IgA vasculitis in a child.
- Author
-
Sandhu K, Mcdonald K, Langmead L, and Deb P
- Subjects
- Humans, Female, Child, Capsule Endoscopy, Methylprednisolone therapeutic use, Immunoglobulin A immunology, Ileitis diagnosis, Ileitis complications, IgA Vasculitis diagnosis, IgA Vasculitis complications
- Abstract
A girl in middle childhood was referred to the paediatric surgical team with acute colicky abdominal pain and bile-stained vomiting. This was preceded by a viral illness. Investigations revealed raised inflammatory markers, and imaging of the abdomen demonstrated ileal and jejunal thickening. Concerns were raised regarding whether she had inflammatory bowel disease. Endoscopy revealed gastritis and duodenitis, and colonoscopy was unremarkable. Video capsule endoscopy demonstrated ulcers in the jejunum and ileum.On day 8 of admission, she developed a symmetrical purpuric rash over both ankles leading to the diagnosis of Henoch-Schonlein-related ileitis. Multidisciplinary team working led to appropriate management of the patient and avoided surgery. Video capsule endoscopy enabled visualisation of the small bowel. She was managed with 5 days of methylprednisolone followed by oral steroids. She made a good recovery with no sequelae. This case highlighted that terminal ileitis is a rare complication of IgA vasculitis with a good prognosis., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
27. IgA vasculitis nephritis: insights from kidney biopsies.
- Author
-
Haas M
- Subjects
- Child, Humans, Kidney pathology, Biopsy, IgA Vasculitis diagnosis, IgA Vasculitis pathology, Glomerulonephritis, IGA drug therapy, Nephritis
- Abstract
Purpose of Review: To present findings indicating the value of kidney biopsy in assessing prognosis and guiding clinical approach to patients with IgA vasculitis nephritis (IgAVN), including a recent international study examining the value of the Oxford (MEST-C) classification., Recent Findings: Historically, kidney biopsies with IgAVN are scored using the International Society for Kidney Diseases in Children (ISKDC) classification. However, this classification has limited prognostic value, and most biopsies fall into just two of the six ISKDC grades. There are few studies examining the clinical value of the Oxford classification, which is well documented to be predictive of kidney outcomes in IgA nephropathy, in IgAVN. However, a recent study of 361 biopsied patients with IgAVN showed that endocapillary hypercellularity (Oxford E1) predicted a subclass of patients showing initial improvement in kidney function with immunosuppressive treatment, followed by a later decline., Summary: Kidney outcome in patients with biopsied IgAVN treated with immunosuppression is determined by clinical factors and endocapillary hypercellularity. The latter is not part of the ISKDC classification and supports including MEST-C scores in biopsy reports of IgAVN. Even patients showing a good initial response to immunosuppression require long-term follow-up due to risk of subsequent kidney function decline., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
28. Staphylococcus aureus induced purpura fulminans.
- Author
-
Sweeney PL, Morison DG, and Bojanowski CM
- Subjects
- Humans, Staphylococcus aureus, Purpura Fulminans etiology, Staphylococcal Infections complications, Staphylococcal Infections diagnosis, IgA Vasculitis diagnosis
- Published
- 2024
- Full Text
- View/download PDF
29. Deregulation in adult IgA vasculitis skin as the basis for the discovery of novel serum biomarkers.
- Author
-
Bajželj M, Hladnik M, Blagus R, Jurčić V, Markež A, Toluay TD, Sodin-Šemrl S, Hočevar A, and Lakota K
- Subjects
- Adult, Humans, Interleukin-18, Leptin, Matrix Metalloproteinase 1, Osteopontin, Adiponectin, Ligands, Inflammation, Kallikreins, Chemokines, IgA Vasculitis diagnosis, IgA Vasculitis genetics
- Abstract
Introduction: Immunoglobulin A vasculitis (IgAV) in adults has a variable disease course, with patients often developing gastrointestinal and renal involvement and thus contributing to higher mortality. Due to understudied molecular mechanisms in IgAV currently used biomarkers for IgAV visceral involvement are largely lacking. Our aim was to search for potential serum biomarkers based on the skin transcriptomic signature., Methods: RNA sequencing analysis was conducted on skin biopsies collected from 6 treatment-naïve patients (3 skin only and 3 renal involvement) and 3 healthy controls (HC) to get insight into deregulated processes at the transcriptomic level. 15 analytes were selected and measured based on the transcriptome analysis (adiponectin, lipopolysaccharide binding protein (LBP), matrix metalloproteinase-1 (MMP1), C-C motif chemokine ligand (CCL) 19, kallikrein-5, CCL3, leptin, C-X-C motif chemokine ligand (CXCL) 5, osteopontin, interleukin (IL)-15, CXCL10, angiopoietin-like 4 (ANGPTL4), SERPIN A12/vaspin, IL-18 and fatty acid-binding protein 4 (FABP4)) in sera of 59 IgAV and 22 HC. Machine learning was used to assess the ability of the analytes to predict IgAV and its organ involvement., Results: Based on the gene expression levels in the skin, we were able to differentiate between IgAV patients and HC using principal component analysis (PCA) and a sample-to-sample distance matrix. Differential expression analysis revealed 49 differentially expressed genes (DEGs) in all IgAV patient's vs. HC. Patients with renal involvement had more DEGs than patients with skin involvement only (507 vs. 46 DEGs) as compared to HC, suggesting different skin signatures. Major dysregulated processes in patients with renal involvement were lipid metabolism, acute inflammatory response, and extracellular matrix (ECM)-related processes. 11 of 15 analytes selected based on affected processes in IgAV skin (osteopontin, LBP, ANGPTL4, IL-15, FABP4, CCL19, kallikrein-5, CCL3, leptin, IL-18 and MMP1) were significantly higher (p-adj < 0.05) in IgAV serum as compared to HC. Prediction models utilizing measured analytes showed high potential for predicting adult IgAV., Conclusion: Skin transcriptomic data revealed deregulations in lipid metabolism and acute inflammatory response, reflected also in serum analyte measurements. LBP, among others, could serve as a potential biomarker of renal complications, while adiponectin and CXCL10 could indicate gastrointestinal involvement., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
30. Prognostic Scoring in IgA Vasculitis.
- Author
-
Glassock RJ
- Subjects
- Humans, Prognosis, IgA Vasculitis complications, IgA Vasculitis diagnosis
- Published
- 2024
- Full Text
- View/download PDF
31. Hemorrhagic bullous IgA vasculitis in pediatric skin of color: an mpox mimicker.
- Author
-
Bui IT, Silfvast-Kaiser AS, Hudson A, Saad SS, and Albahra SM
- Subjects
- Child, Humans, Hemorrhage diagnosis, Hemorrhage etiology, Immunoglobulin A, Skin, Diagnosis, Differential, Ethnic and Racial Minorities, IgA Vasculitis complications, IgA Vasculitis diagnosis, Mpox (monkeypox)
- Published
- 2024
- Full Text
- View/download PDF
32. A rare twist: COVID-19 infection masquerading as IgA vasculitis in a hemophilia a patient.
- Author
-
Alnaqbi KA, Abunamous N, and Saleem T
- Subjects
- Male, Adult, Humans, Young Adult, Skin pathology, Gastrointestinal Tract, IgA Vasculitis complications, IgA Vasculitis diagnosis, IgA Vasculitis pathology, Hemophilia A complications, Hemophilia A diagnosis, Hemophilia A pathology, COVID-19 complications, COVID-19 diagnosis
- Abstract
Hemophilia A and B are one of the most common hereditary bleeding disorders. Patients are predisposed to bleeding spontaneously or after minor trauma in different areas such as the skin, gastrointestinal, or joints. COVID-19 infection has been associated with various clinical manifestations and complications including rarely triggering IgA vasculitis. We report a 23-year-old man who was previously diagnosed with severe hereditary hemophilia A. He presented to our hospital with classic symptoms of IgA vasculitis, complaining of petechiae and purpura in his limbs, fatigue, body aches, poor oral intake, abdominal pain, and watery non-bloody diarrhea. He did not present with respiratory symptoms or fever typical of COVID-19 infection. Abnormal blood tests were mildly elevated C-reactive protein, elevated d-dimers, and low Factor VIII activity. Extensive immunological tests were negative. CT abdomen with contrast was unremarkable. A skin biopsy strongly indicated IgA vasculitis. COVID-19 test came back positive. The patient was managed symptomatically and with glucocorticosteroids which significantly improved his symptoms. The available literature on clinical features, laboratory tests, and management of COVID-19-associated IgA vasculitis is discussed. However, there is no case reported on the associations between hemophilia, COVID-19 infection, and IgA vasculitis. This is the first case of atypical COVID-19 infection masquerading as de novo IgA vasculitis in an adult patient with underlying hemophilia. Our case contributes to the growing body of literature about hemophilia being a possible predisposing factor that a COVID-19 virus relies on to amplify immune dysregulation resulting in IgA vasculitis., (© 2024. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).)
- Published
- 2024
- Full Text
- View/download PDF
33. Erythrocyte Glutathione S-Transferase Activity as a Sensitive Marker of Kidney Function Impairment in Children with IgA Vasculitis.
- Author
-
Frkovic M, Turcic A, Gagro A, Srsen S, Frkovic SH, Rogic D, and Jelusic M
- Subjects
- Child, Humans, Erythrocytes, Glutathione Transferase, Kidney, IgA Vasculitis diagnosis, Sodium Oxybate, Nephritis
- Abstract
IgA vasculitis (IgAV) is the most common childhood vasculitis. The main cause of morbidity and mortality in children with IgAV is nephritis (IgAVN), but the risk of its development, severity, and chronicity remain unclear. Erythrocyte glutathione S-transferase (e-GST) activity has been previously detected as a sensitive marker of kidney function impairment in several diseases. We spectrophotometrically assessed and correlated e-GST activity between 55 IgAV patients without nephritis (IgAVwN), 42 IgAVN patients, and 52 healthy controls. At disease onset, e-GST activity was significantly higher in IgAVN patients (median (interquartile range)) (5.7 U/gHb (4.4-7.5)) than in IgAVwN patients (3.1 U/gHb (2.2-4.2); p < 0.001), and controls (3.1 U/gHb (1.9-4.2); p < 0.001). Therewithal, there were no differences between the IgAVwN patients and controls ( p = 0.837). e-GST activity was also significantly higher in the IgAVN patients than in the IgAVwN patients after 3 months (5.0 U/gHb (4.2-6.2) vs. 3.3 U/gHb (2.3-4.1); p < 0.001) and 6 months (4.2 U/gHb (3.2-5.8) vs. 3.3 U/gHb (2.1-4.1); p < 0.001) since the disease onset. Consistent correlations between e-GST activity and serum creatinine, estimated glomerular filtration rate (eGFR), and proteinuria levels were not detected. In conclusion, increased e-GST activity can serve as a subtle indicator of kidney function impairment in children with IgAV.
- Published
- 2024
- Full Text
- View/download PDF
34. Palpable Purpura.
- Author
-
Novotny RW, Trinh LN, Gowan AJ, and Lomeli MC MD
- Subjects
- Humans, Purpura diagnosis, Purpura etiology, IgA Vasculitis diagnosis, Skin Neoplasms
- Published
- 2024
35. Modern diagnostic methods for early assessment of the abdominal involvement in Schönlein-Henoch disease.
- Author
-
Vasileva AV, Chakarov I, and Chakarova P
- Subjects
- Humans, Skin, Kidney, Abdomen, IgA Vasculitis complications, IgA Vasculitis diagnosis
- Abstract
Introduction: Schönlein-Henoch disease is a small vessel vasculitis resulting from IgA-mediated inflammation. It is the most common acute systemic vasculitis in childhood, mainly affecting the skin, gastrointestinal tract, joints, and kidneys. Although the prognosis of Schönlein-Henoch is generally good, gastrointestinal tract involvement is a potential complication, presenting as massive gastrointestinal bleeding, bowel infarction, perforation, as well as intussusception and peritonitis., (This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
36. Standardization of the management of rheumatoid purpura nephropathy in the West of France. What are the repercussions on the renal sequelae?
- Author
-
Salmon M, Rousseau C, Roussey G, Jay N, Cloarec S, Injeyan M, Ryckewaert A, and Taque S
- Subjects
- Child, Humans, Kidney pathology, Disease Progression, France, Reference Standards, Biopsy, IgA Vasculitis complications, IgA Vasculitis diagnosis, IgA Vasculitis therapy, Kidney Diseases complications
- Abstract
Introduction: Rheumatoid purpura is the most common vasculitis in children, and its renal involvement determines the prognosis. To date, no national protocol exists for its management. A protocol was drafted for the French Grand Ouest inter-region in 2011 in order to standardize practices., Objectives: The main objective is to evaluate renal sequelae with a median follow-up of 2 years since the implementation of this protocol. The secondary objectives are to evaluate the different therapeutic and diagnostic management., Method: Inclusion of all children from 2006 to 2018 with nephropathy due to rheumatoid purpura followed in the university hospitals of Rennes, Nantes, Tours, Angers and Brest., Results: 169 patients were included, of whom 104 were treated accroding to protocol and 65 differently. Sequels at 2-year follow-up concerned 27.0% of patients with no significant difference according to whether or not the protocol was followed. A significant decrease of 26.1% in the number of renal biopsies was observed in the group that followed the protocol. The latter was performed with a median delay of less than 30 days., Conclusion: The protocol allowed a standardization of practices without deleterious consequences at 2 years of follow-up and a decrease in renal biopsy punctures. It is in agreement with the recommendations of KDIGO (Kidney Disease Improving Global Outcomes) and European experts. On the other hand, in view of recent studies and the physiopathology, immunosuppressive drugs other than corticosteroids could be introduced earlier in severe forms.
- Published
- 2024
- Full Text
- View/download PDF
37. Response to: Adult IgA vasculitis-look for triggers.
- Author
-
Tadokoro T, Abe T, Nakano T, Kimura Y, Higaki K, Hayashidani S, and Tashiro H
- Subjects
- Adult, Humans, Immunoglobulin A, IgA Vasculitis complications, IgA Vasculitis diagnosis, Vasculitis diagnosis
- Published
- 2024
- Full Text
- View/download PDF
38. Adult IgA vasculitis-look for triggers.
- Author
-
Sethi J
- Subjects
- Adult, Humans, Immunoglobulin A, IgA Vasculitis diagnosis, Vasculitis diagnosis
- Published
- 2024
- Full Text
- View/download PDF
39. Epidemiology and clinical characteristics of biopsy-confirmed adult-onset IgA vasculitis in southern Sweden.
- Author
-
Thalen M, Gisslander K, Segelmark M, Sode J, Jayne D, and Mohammad AJ
- Subjects
- Male, Adult, Humans, Female, Child, Retrospective Studies, Sweden epidemiology, Immunoglobulin A, Biopsy, IgA Vasculitis diagnosis, IgA Vasculitis epidemiology, Vasculitis epidemiology, Renal Insufficiency, Chronic
- Abstract
Objective: Immunoglobulin A vasculitis (IgAV) is the most prevalent primary childhood vasculitis in Sweden, but is considerably rarer in adults. This study aims to describe the epidemiology, clinical characteristics and renal outcome of adult-onset IgAV in Skåne, Sweden., Methods: The study area consisted of Skåne, the southernmost region of Sweden, with a population ≥18 years of 990 464 on 31 December 2010. Adult patients assigned the International Classification of Diseases-10 code for IgAV (D69.0) from 2000 through 2019 were retrospectively identified in a population-based database. Medical records were reviewed to validate the diagnosis of IgAV and extract data. Only patients with clinical manifestations of IgAV and biopsy-confirmed disease were included. The annual incidence and point prevalence of biopsy-confirmed IgAV were estimated., Results: Fifty-nine patients (19 women) were classified as having adult-onset IgAV. The incidence was 3 per 1 000 000 and was higher among men than women (4 vs 2/1 000 000, p=0.004). Ninety-seven per cent of patients presented with non-thrombocytopenic purpura, 78% with renal involvement, 59% with arthritis/arthralgia and 39% with gastrointestinal symptoms. Fifteen per cent developed chronic kidney disease stage ≥G3 a and one patient progressed to end-stage kidney disease during follow-up., Conclusion: Adult-onset IgAV is rare in southern Sweden with the incidence higher in men than in women. IgAV frequently affects the kidneys and leads to chronic kidney disease in adults, although the long-term renal outcome appears favourable compared with other small-vessel vasculitides affecting the kidneys., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
40. [Immunoglobulin A vasculitis].
- Author
-
Adler S
- Subjects
- Adult, Humans, Child, Antigen-Antibody Complex therapeutic use, Immunoglobulin A, IgA Vasculitis diagnosis, Vasculitis diagnosis, Polyarteritis Nodosa, Vasculitis, Leukocytoclastic, Cutaneous
- Abstract
The immune-mediated small vessel vasculitis is known as Schoenlein-Henoch purpura predominantly from pediatrics and in these cases occurs more frequently after infections of the upper airways. In adults, immunoglobulin A (IgA) vasculitis often proceeds more severely und recurrently with the classical tetrad of skin manifestations in the sense of leukocytoclastic vasculitis, joint affection, gastrointestinal involvement and IgA nephritis, in contrast to the mostly mild and self-limiting course in children. The background of this systemic vasculitis with formation of IgA immune complexes is considered to be an altered glycosylation of IgA, as this causes the exposure of binding sites for autoantibodies so that an immune complex reaction can be elicited. This ultimately leads to perivascular deposition of IgA and a further activation of neutrophils. Groundbreaking in the diagnostics is the histological detection of leukocytoclastic vasculitis and in cases of renal manifestations a kidney biopsy with characteristic deposits of immune complexes, which cannot be clearly differentiated from IgA nephropathy. The treatment is aimed at the respective manifestation and is mostly based on consensus recommendations due to the lack of randomized studies. In addition to immunosuppressive medication, in the presence of a chronic kidney disease general nephroprotection is becoming increasingly more important also by inhibition of sodium-glucose transporter 2 (SGLT2). The type and extent of kidney involvement and also rare cardiac manifestations are the main determinants of the prognosis. Continuous medical accompaniment of those affected is necessary due to the possible progression of the disease and the risk of recurrence., (© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
41. A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future.
- Author
-
Parums DV
- Subjects
- Child, Humans, Immunoglobulin A therapeutic use, Kidney Glomerulus, IgA Vasculitis diagnosis, IgA Vasculitis drug therapy, Glomerulonephritis, IGA diagnosis, Glomerulonephritis, IGA complications, Vasculitis diagnosis, Hypersensitivity
- Abstract
The clinical association of purpura, arthralgia, and arthritis was first described in 1837 in a publication by Johann Lukas Schönlein, a German physician. In 1874, Eduard Henoch, a student of Schönlein, reported cases of children with purpura, abdominal pain, bloody diarrhea, and joint pain. IgA vasculitis, or Henoch-Schönlein purpura, is a systemic hypersensitivity vasculitis caused by the deposition of immune complexes in small blood vessels, including the renal glomeruli and mesangium. In the skin, the presentation is with non-thrombocytopenic purpura or urticaria. Worldwide, IgA nephropathy is the most common cause of primary glomerulonephritis. Detection of IgA deposition in small blood vessels and the renal glomeruli is diagnostic in most cases. This article aims to review the history, current classification, epidemiology, presentation, and diagnosis of IgA vasculitis and nephropathy, disease associations or trigger factors, including infections, vaccines, and therapeutic agents, and highlights some future approaches to improve diagnosis and clinical management.
- Published
- 2024
- Full Text
- View/download PDF
42. Characteristics of renal pathology and coagulation function in IgA nephropathy and IgA vasculitis associated nephritis.
- Author
-
Wang Y, Wang H, Ma X, Zhu Z, Tian X, Fu R, and Jia L
- Subjects
- Humans, Retrospective Studies, Kidney pathology, Fibrinogen, Glomerulonephritis, IGA diagnosis, IgA Vasculitis diagnosis, Nephritis etiology
- Abstract
Background: The objective of this study is to investigate the clinical and pathological differences between patients with IgA nephropathy (IgAN) and IgA vasculitis associated nephritis (IgAVN)., Methods: A total of 253 patients with IgAN and 71 patients with IgAVN were retrospectively included in the study, and clinical and laboratory data were collected and analysed., Results: Compared with IgAVN group, months from onset to kidney biopsy were significantly prolonged in IgAN patients because of the lack of obvious symptoms such as rash, abdominal symptoms, and joint pain (13.5 ± 26.6 vs. 10.2 ± 31.6 months, P = 0.007), and the levels of serum creatinine (92.3 ± 94.7 vs. 68.9 ± 69.2 µmol/L, P = 0.015) was higher and eGFR (99.1 ± 35.2 vs. 123.4 ± 41.8 mL/min/1.73m
2 , P < 0.001) was lower in IgAN group. The pathological results revealed that patients with IgAN have a greater degree of chronic kidney injury compared to patients with IgAVN. In addition, the levels of plasma D-Dimers (1415.92 ± 1774.69 vs. 496.78 ± 711.91 ng/mL, P < 0.001) and fibrinogen degradation products (FDP) (3.92 ± 4.73 vs. 1.63 ± 2.46 µg/mL, P = 0.001) were significantly higher in IgAVN patients than in IgAN patients. The deposition of fibrinogen in the renal tissues was more severe and the cumulative partial remission rate was higher in patients with IgAVN as compared to those with IgAN (P = 0.001)., Conclusions: In comparison, IgAN patients had poorer renal function, whereas IgAVN patients had more severe coagulation abnormalities. These findings provide a basis for the differentiation of the two diseases at an early stage., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
43. Comparison of Different Treatment Regimens for Long-term Improvement of Renal Function in Patients with Henoch-Schönlein Purpura: A Systematic Review.
- Author
-
Reicy R and Jari M
- Subjects
- Humans, Child, Child, Preschool, Cyclosporine therapeutic use, Retrospective Studies, Prospective Studies, Immunosuppressive Agents therapeutic use, Methylprednisolone therapeutic use, Kidney, IgA Vasculitis complications, IgA Vasculitis drug therapy, IgA Vasculitis diagnosis
- Abstract
Backgrounds: Henoch-Schönlein purpura (IgA vasculitis) is the most common childhood vasculitis, one of its complications is renal involvement. However, several treatment regimens have been proposed to improve renal function in the long term, but which drug regimen can be most effective is still controversial., Methods: This study was a systematic review. In order to find evidence related to the purpose of this study, databases including Google Scholar, Web of Science, ProQuest and Medline via PubMed, and Scopus were searched with the appropriate keywords. QUADAS-2 (a Quality Assessment tools for Diagnostic Accuracy Studies) checklist was also used to evaluate the quality of studies. Based on the keywords used in reviewing the information sources of scientific articles, in the first stage, 86 studies were included in the review. Taking into account characteristics such as lack of homogeneity with the objectives of the present study, finally, 11 studies were selected for analysis and final evaluation., Results: A total of 11 studies, including 722 patients in the age range of 5.5 to 9.9 years with HSP were included in the study. The follow-up period of the patients varied from 6 months to 16 years in terms of examining the treatment process. In terms of study type, 7 studies were conducted as prospective or retrospective (non-interventional) cohorts and 4 studies as randomized clinical trials. The treatment regimen of injectable methylprednisolone followed by oral prednisolone resulted in a long-term recovery of 79.2% (95% confidence interval between 0.66% and 88.2%); however, the need for additional immunosuppressive in two studies was mentioned as 38% and 46.1%, respectively. In the therapeutic regimen of oral methylprednisolone alone, a significant improvement in long-term renal function was achieved in comparison with placebo. Administration of injectable methylprednisolone followed by cyclosporine A had the highest effectiveness in terms of improving renal function in the long term., Conclusion: Regimes based on the administration of prednisolone (either oral or injectable, either as a single drug or as a combination) lead to long-term improvement of renal function in patients with HSP, but the use of other immunosuppressive drugs such as cyclosporine A, of course, with optimizing the drug dose can lead to a significant improvement in the clinical performance., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2024
- Full Text
- View/download PDF
44. Clinical characteristics and risk factors for kidney involvement in children with immunoglobulin A vasculitis.
- Author
-
Chatpaitoon B, Rianthavorn P, Chanakul A, and Khaosut P
- Subjects
- Humans, Male, Female, Child, Risk Factors, Child, Preschool, Adolescent, Retrospective Studies, Proteinuria etiology, Proteinuria epidemiology, Kaplan-Meier Estimate, Hematuria etiology, Hematuria epidemiology, Logistic Models, Kidney pathology, Glomerulonephritis, IGA complications, Glomerulonephritis, IGA epidemiology, IgA Vasculitis complications, IgA Vasculitis epidemiology, IgA Vasculitis diagnosis
- Abstract
Background: Immumoglobulin A (IgA) vasculitis (IgAV), formerly known as Henoch-Schönlein purpura (HSP), is a self-limiting systemic vasculitis in children. Kidney involvement is associated with a long-term unfavorable outcome and can lead to significant morbidity. This study was conducted to describe the clinical and laboratory characteristics of childhood IgAV with kidney involvement and to identify risk factors associated with IgAV nephritis (IgAVN)., Methods: This was an ambidirectional descriptive study of 77 children with IgAV. All demographic data, clinical features, and laboratory tests were collected from electronic medical records from January 2010 to December 2022. Risk factors for kidney involvement in IgAV were assessed using multivariate logistic regression. Kaplan-Meier survival analysis was used to calculate the time to commencement of kidney involvement., Results: Twenty-five children (32.4% of the IgAV patients) developed IgAVN. The common findings in IgAV with kidney involvement were microscopic hematuria (100%), nephrotic range proteinuria (44%), and non-nephrotic range proteinuria (40%). Multivariate logistic regression showed that age greater than 10 years (adjusted hazard ratio, AHR 4.66; 95% confidence interval, CI, 1.91-11.41; p = 0.001), obesity (body mass index, BMI, z-score ≥ +2 standard deviations, SDs) (AHR 3.59; 95% CI 1.41-9.17; p = 0.007), and hypertension at onset (AHR 4.78; 95% CI 1.76-12.95; p = 0.002) were associated significantly with kidney involvement. During follow up, most IgAV patients developed nephritis within the first 9 months., Conclusion: Age greater than 10 years, obesity, and hypertension at presentation were predictive factors for IgAVN. Our study emphasized that IgAV patients with risk factors should be closely monitored for at least 1 year after the onset of the disease., (© 2024 Japan Pediatric Society.)
- Published
- 2024
- Full Text
- View/download PDF
45. Henoch-schonlein purpura following exposure to SARS-CoV2 vaccine or infection: a systematic review and a case report.
- Author
-
Di Vincenzo F, Ennas S, Pizzoferrato M, Bibbò S, Porcari S, Ianiro G, and Cammarota G
- Subjects
- Humans, Immunoglobulin A, Pandemics, RNA, Viral, SARS-CoV-2, COVID-19 complications, IgA Vasculitis complications, IgA Vasculitis diagnosis, IgA Vasculitis pathology, Vaccines
- Abstract
Background: Henoch-Schonlein purpura (HSP) is an IgA-mediated systemic small-vessel vasculitis (IgAV) that typically presents with a variable tetrad of symptoms. HSP if often preceded by respiratory tract infections, vaccinations, drugs or malignancies. During the recent COVID-19 pandemic multiples cases of HSP have been described after both infection and vaccination for SARS-CoV2. This study aims to perform a systematic review of literature and describe an additional complicated case of de-novo HSP appeared after the administration of the third dose of a mRNA-SARS-CoV2 vaccination., Methods: Electronic bibliographic research was performed to identify all the original reports describing cases of de-novo HSP or IgAV appeared after respiratory infection or vaccine administration for SARS-CoV2. We included all case series or case reports of patients who respected our inclusion and exclusion criteria., Results: Thirty-eight publications met our pre-defined inclusion criteria, for an overall number of 44 patients. All patients presented with palpable purpura variable associated with arthralgia, abdominal pain or renal involvement. Increased levels of inflammation markers, mild leukocytosis and elevated D-dimer were the most common laboratory findings. Up to 50% of patients presented proteinuria and/or hematuria. Almost all skin biopsies showed leukocytoclastic vasculitis, with IgA deposits at direct immunofluorescence in more than 50% of cases., Conclusions: Our results suggest that the immune response elicited by SARS-CoV2 vaccine or infection could play a role in the development of HSP. Current research suggests a possible role of IgA in immune hyperactivation, highlighted by early seroconversion to IgA found in some COVID-19 patients who develop IgA vasculitis., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
46. IgA Vasculitis as a Potential Complication of Fourth-Line Chemotherapy with Tegafur/Gimeracil/Oteracil (S-1) in Advanced Non-Small Cell Lung Cancer: A Case Report.
- Author
-
Yoneoka R, Kasai H, Hino A, Hayashi A, Sasaki A, Ota M, Asanuma K, and Suzuki T
- Subjects
- Male, Humans, Aged, Oxonic Acid adverse effects, Tegafur adverse effects, Ascites complications, Immunoglobulin A therapeutic use, Steroids therapeutic use, IgA Vasculitis chemically induced, IgA Vasculitis diagnosis, IgA Vasculitis complications, Carcinoma, Non-Small-Cell Lung drug therapy, Lung Neoplasms drug therapy, Lung Neoplasms complications, Purpura complications, Paraneoplastic Syndromes
- Abstract
BACKGROUND Immunoglobulin A (IgA) vasculitis is a systemic vasculitis that involves the small vessels. It is mainly characterized by skin symptoms such as purpura, arthritis/arthralgia, abdominal symptoms, and nephropathy, which are caused by IgA adherence to the vessel walls. Herein, we report the case of an advanced non-small cell lung cancer (NSCLC) and a purpuric skin rash of the legs that developed during fourth-line chemotherapy with tegafur/gimeracil/oteracil (S-1). CASE REPORT A 68-year-old man diagnosed with NSCLC 2 years ago was undergoing S-1 as fourth-line chemotherapy when he developed purpura and edema on the lower extremities. Biopsy renal specimens were consistent with IgA vasculitis. Considering his medical history, both IgA vasculitis induced by S-1 and a paraneoplastic syndrome were considered, although the exact cause could not be identified. Subsequently, chemotherapy was discontinued because of his deteriorating general condition, and he received optimal supportive care. The purpura spontaneously disappeared; however, his ascites and renal function deteriorated. Systemic steroids improved renal function, but the ascites did not resolve. One month after being diagnosed with IgA vasculitis, the patient died due to deterioration of his general condition. CONCLUSIONS This case emphasizes the occurrence of IgA vasculitis during lung cancer treatment and its potential impact on the disease course of lung cancer. Moreover, the possible causes of IgA vasculitis in this case were paraneoplastic syndrome or S-1 adverse effects, but further case series are needed to gain a more comprehensive understanding. Refractory, steroid-unresponsive ascites may occur as an abdominal manifestation of IgA vasculitis.
- Published
- 2023
- Full Text
- View/download PDF
47. IgA Vasculitis in an Adult Linked to Cryptosporidium and Giardia Co-Infection: A Comprehensive Case Study.
- Author
-
Castellino J, Orentas M, Hassan D, and Khandelwal S
- Subjects
- Male, Adult, Child, Humans, Middle Aged, Giardia, Immunoglobulin A, IgA Vasculitis complications, IgA Vasculitis diagnosis, IgA Vasculitis pathology, Coinfection, Cryptosporidium, Cryptosporidiosis complications, Vasculitis complications, Vasculitis diagnosis, Exanthema
- Abstract
BACKGROUND Immunoglobulin A (IgA) vasculitis is a small-vessel vasculitis characterized by the deposition of IgA immune complexes primarily in the skin, kidneys, and gastrointestinal tract. While it predominantly affects children, cases in adults are associated with more severe manifestations. Evidence suggests that infectious triggers play a pivotal role in its etiology. Often, it follows a self-limiting course and doesn't necessitate intervention. CASE REPORT We present the case of a 51-year-old man who presented with a maculopapular rash, arthralgia, and abdominal pain. An examination revealed a purpuric rash on lower extremities and abdomen. A lower extremity duplex ultrasound identified deep vein thrombosis (DVT) in the right leg. Skin biopsy of the rash confirmed the diagnosis of IgA vasculitis, demonstrating perivascular neutrophilic infiltrate and IgA complex deposition. Stool studies revealed co-infection with Cryptosporidium and Giardia. The patient was treated with a prednisone taper with significant improvement in symptoms. CONCLUSIONS This case highlights the potential role of Cryptosporidium as a trigger for IgA vasculitis. The presence of concurrent infections underscores the complex interplay between infections and the development of IgA vasculitis. The co-infection with Giardia suggests that a secondary infection may be involved, further complicating the disease's etiology. The observation of DVT suggests a possible link between IgA vasculitis and a prothrombotic state. This report serves to expand the knowledge of IgA vasculitis triggers and associated complications, guiding clinicians in diagnosing and managing similar cases while emphasizing the importance of vigilance in adults with these symptoms.
- Published
- 2023
- Full Text
- View/download PDF
48. Rituximab as possible therapy in TNF inhibitor-induced IgA vasculitis with severe renal involvement.
- Author
-
Przygocka A, Berti GM, Campus A, Tondolo F, Vischini G, Fabbrizio B, La Manna G, and Baraldi O
- Subjects
- Humans, Rituximab adverse effects, Adalimumab adverse effects, Tumor Necrosis Factor Inhibitors adverse effects, Quality of Life, Renal Dialysis, Adrenal Cortex Hormones, IgA Vasculitis chemically induced, IgA Vasculitis diagnosis, IgA Vasculitis drug therapy, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis complications
- Abstract
Background: We observe the increasing use of tumor necrosis factor (TNF) inhibitors in patients affected by chronic inflammatory diseases. These drugs provide good control of symptoms, contributing to significant improvement in the quality of life in individuals with high disease burden. On the other hand, along with their wider use and longer follow-up periods the number of reports regarding their adverse effects is also increasing. The reported complications include drug-induced vasculitis with possible kidney involvement. In the literature we can distinguish more frequently described ANCA-associated vasculitis and more rarely occurring immunoglobulin A vasculitis. Although uncommon, such complications may present with potentially life-threatening vital organ dysfunction; therefore, adequate monitoring and effective therapy are necessary., Case Presentation: We report two cases of TNF inhibitor-induced vasculitis with severe acute worsening of renal function and significant proteinuria. The first patient was receiving golimumab therapy for ankylosing spondylitis and the second patient was treated with adalimumab for psoriasis and psoriatic arthritis. In the second case dialysis treatment was necessary and the patient presented recurrence of vasculitis after rechallenge with adalimumab. Both patients underwent renal biopsy which showed findings compatible with drug-induced IgA vasculitis and both were treated successfully with corticosteroids and rituximab., Conclusions: To the best of our knowledge this is the first report of rituximab use in drug-induced IgA vasculitis with renal involvement. Combination of corticosteroids and rituximab can be an effective therapy in case of vasculitis with kidney failure and a preferable option for selected patients with drug-induced IgA vasculitis compared to cyclophosphamide. More studies are necessary to establish suitable short- and long-term treatment. Given the rarity of this disorder, case reports and case series can provide practical guidance until additional studies become available., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
49. Online information-seeking behavior of Iranian web users on Google about Henoch-Schönlein purpura (HSP): an infodemiology study.
- Author
-
Javadi V, Kamfar S, Zeinali V, Rahmani K, and Moghaddamemami FH
- Subjects
- Humans, Iran epidemiology, Information Seeking Behavior, Infodemiology, Search Engine, IgA Vasculitis epidemiology, IgA Vasculitis complications, IgA Vasculitis diagnosis
- Abstract
Backgrounds: Previous studies have indicated that users' health information-seeking behavior can serve as a reflection of current health issues within a community. This study aimed to investigate the online information-seeking behavior of Iranian web users on Google about Henoch-Schönlein purpura (HSP)., Methods: Google Trends (GTr) was utilized to collect big data from the internet searches conducted by Iranian web users. A focus group discussion was employed to identify users' selected keywords when searching for HSP. Additionally, keywords related to the disease's symptoms were selected based on recent clinical studies. All keywords were queried in GTr from January 1, 2012 to October 30, 2022. The outputs were saved in an Excel format and analyzed using SPSS., Results: The highest and lowest search rates of HSP were recorded in winter and summer, respectively. There was a significant positive correlation between HSP search rates and the terms "joint pain" (P = 0.007), "vomiting" (P = 0.032), "hands and feet swelling" (P = 0.041) and "seizure" (P < 0.001)., Conclusion: The findings were in accordance with clinical facts about HSP, such as its seasonal pattern and accompanying symptoms. It appears that the information-seeking behavior of Iranian users regarding HSP can provide valuable insights into the outbreak of this disease in Iran., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
50. [Chinese guidelines for the diagnosis and management of childhood IgA vasculitis (2023)].
- Subjects
- Humans, Immunoglobulin A, IgA Vasculitis diagnosis, IgA Vasculitis therapy, Vasculitis diagnosis, Vasculitis therapy
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.